BioNexus Gene Lab Corp SEC filings BGLC
BioNexus Gene Lab Corp has 157 filings in SEC EDGAR's recent list, going back to Jan 29, 2019. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| DEFR14A | Defr 14a | Feb 28, 2025 | — |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| UPLOAD | Letter from the SEC | Jun 6, 2024 | — |
| CORRESP | Letter to the SEC | May 23, 2024 | — |
| UPLOAD | Letter from the SEC | May 6, 2024 | — |
| NT 10-K | Filing | Mar 28, 2024 | Dec 31, 2023 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Aug 14, 2023 | Jun 30, 2023 |
| CERT | Filing | Jul 20, 2023 | — |
| EFFECT | Filing | Jul 19, 2023 | — |
| 8-A12B | Form 8-a12b | Jul 19, 2023 | — |
| DEFR14C | Filing | Mar 10, 2023 | — |
| NT 10-K | Filing | Apr 1, 2022 | Dec 31, 2021 |
| NT 10-Q | Filing | May 17, 2021 | Mar 31, 2021 |
| NT 10-K | Filing | Mar 30, 2020 | Dec 31, 2019 |
| EFFECT | Filing | Apr 3, 2019 | — |
| CORRESP | Letter to the SEC | Apr 2, 2019 | — |
| CORRESP | Letter to the SEC | Apr 2, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2019 | — |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BGLC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- WY
- Headquarters
- Kuala Lumpur
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1737523
- Former names
- BioNexus Gene Lab Coporation (until May 8, 2020)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.